Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
Entrada Therapeutics Inc (TRDA)
Entrada Therapeutics Inc (TRDA) Financials

TRDA Entrada Therapeutics Inc

18.80

0.75 (4.16%)

23 Nov 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-33.455	-33.919	-1.854
Return on Equity (%)	-34.252	-37.012	-2.939
Return on Invested Capital (%)	-34.331	-38.803	-9.978
Operating Margin (%)	N/A	N/A	9.345
Net Profit Margin (%)	N/A	N/A	-5.182
Book Value Per Share	9.567	6.77	7.263
Earnings Per Share	-1.638	-3.014	-0.2
Cash Per Share	9.322	1.438	2.026
Working Capital Per Share	9.351	5.985	6.323
Operating Profit Per Share	N/A	N/A	3.866
EBIT Per Share	-1.638	-3.014	0.361
EBITDA Per Share	-1.638	-3.014	0.361
Free Cash Flow Per Share	-1.527	-2.982	-0.117

Liquidity Ratios

Year End 31 December 2023	2021	2022	2023
Current Ratio	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A
Shares Outstanding	31.22M	31.4M	N/A

Key Stats and Ratios

Year End 31 December 2023	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	31.33M	31.4M	N/A	33.21M	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	-12.363	N/A	N/A	N/A	42.84
Net Profit Margin (%)	N/A	N/A	N/A	-26.421	N/A	N/A	N/A	39.743
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	675.43M
Price to Earnings Ratio	-104.93
Price to Sales Ratio	5.44
Price to Cash Ratio	10.37
Price to Book Ratio	2.89
Dividend Yield	-

Share Statistics

Shares Outstanding	37.42M
Average Volume (1 week)	96.62k
Average Volume (1 Month)	134.89k
52 Week Change	18.24%
52 Week High	20.49
52 Week Low	10.7501

More Ratios Coming Soon!

Entrada Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions